Jf. Tait et al., Measurement of phosphatidylserine exposure in leukocytes and platelets by whole-blood flow cytometry with annexin V, BL CELL M D, 25(17), 1999, pp. 271-278
Phosphatidylserine (PS) exposure serves as a procoagulant stimulus and a si
gnal for phagocytic clearance of apoptotic cells. In order to measure PS ex
posure in blood cells, we developed a flow-cytometric procedure to measure
annexin V binding to leukocytes and platelets in whole-blood samples. Leuko
cytes were identified by CD45 and side-scatter gating, and platelets by CD6
1 and side-scatter gating, The absolute number of annexin V molecules bound
per cell was determined from an independent calibration procedure, Normal
populations had the following levels of annexin V binding (in molecules per
cell): lymphocytes, 0.53 x 10(3); neutrophils, 1.75 x 10(3); monocytes, 2.
45 x 10(3); platelets, 0.14 x 10(3). These levels represent less than or eq
ual to 0.1% of the values obtained after maximal stimulation of PS exposure
with calcium ionophore, confirming that virtually all PS is intracellular
in normal circulating leukocytes and platelets. Pretreatment of whole-blood
samples with ammonium chloride to lyse erythrocytes caused a 9- to 300-fol
d increase in annexin V binding to leukocytes, indicating that analysis of
unlysed whole-blood samples is essential to avoid artifactual increases in
annexin V binding to leukocytes. Comparison of annexin V with two other mar
kers of platelet activation, CD62P and the activation-dependent epitope of
glycoprotein IIb/IIIa detected by the PAC1 antibody, indicated that platele
ts from normal donors showed the least amount of activation with the annexi
n V marker. Whole-blood flow cytometry with annexin V can reliably measure
the state of PS exposure in platelets and leukocytes, and the results confi
rm that these cell types normally circulate with extremely low levels of ex
posed PS.